The Heart Failure Software market size is USD 2.3 Bn in 2026.
The Heart Failure Software market is projected to grow at ~8% CAGR by 2033, reaching USD 4 Bn.
The Heart Failure Software market growth drivers include rising CVD burden, increasing hospital readmissions, adoption of remote patient monitoring, and AI-enabled clinical decision support.
North America is the dominating region for the Heart Failure Software market.
Philips Healthcare, Medtronic plc, GE Healthcare, Siemens Healthineers, and IBM are some leading industry players in the Heart Failure Software market.